These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 658481)

  • 21. Gynandroblastoma of ovary with juvenile granulosa cell component and heterologous intestinal type glands.
    McCluggage WG; Sloan JM; Murnaghan M; White R
    Histopathology; 1996 Sep; 29(3):253-7. PubMed ID: 8884354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex hormone profiles in oligomenorrheic adolescent girls and the effect of oral contraceptives.
    Siegberg R; Nilsson CG; Stenman UH; Widholm O
    Fertil Steril; 1984 Jun; 41(6):888-93. PubMed ID: 6233177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Theca lutein cysts with maternal virilization and elevated serum testosterone in pregnancy.
    Ito M; Tohya T; Yoshimura T; Matsui K; Fujisaki S; Okamura H
    Acta Obstet Gynecol Scand; 1987; 66(6):565-6. PubMed ID: 2827428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endocrine studies in a case of profound virilization of a woman due an androgen-producing granulosa cell tumor.
    Schwack M; Schindler AE
    Zentralbl Gynakol; 1993; 115(11):508-10. PubMed ID: 8296498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resection of liver metastases from a virilizing steroid (lipoid) cell ovarian tumor.
    Garduño-López AL; Mondragón-Sánchez R; Herrera-Goepfert R; Bernal-Maldonado R
    Hepatogastroenterology; 2002; 49(45):657-9. PubMed ID: 12063963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
    Calogero AE; Macchi M; Montanini V; Mongioi A; Maugeri G; Vicari E; Coniglione F; Sipione C; D'Agata R
    J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pure Leydig cell tumour (hilus cell) of the ovary: a rare cause of virilization after menopause.
    Baiocchi G; Manci N; Angeletti G; Celleno R; Fratini D; Gilardi G
    Gynecol Obstet Invest; 1997; 44(2):141-4. PubMed ID: 9286731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postmenopausal hyperandrogenism: the under-recognized value of inhibins.
    Shearer JL; Salmons N; Murphy DJ; Gama R
    Ann Clin Biochem; 2017 Jan; 54(1):174-177. PubMed ID: 27278937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Extra-ovarian site of a virilizing lipid cell tumor].
    Klaiber H; Genton C; Schreiner W; Keller PJ
    Geburtshilfe Frauenheilkd; 1987 Nov; 47(11):817-20. PubMed ID: 2826286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormonal profile in patients with gonadal dysgenesis.
    Kim MH; Hosseinian AH; Sacris MO; Dupon C; Cleary RE
    Am J Obstet Gynecol; 1974 Apr; 118(7):955-60. PubMed ID: 4818427
    [No Abstract]   [Full Text] [Related]  

  • 31. Hormonal studies and Doppler flow imaging of ovarian lipoid cell tumors: report of two cases.
    Lin YF; Chen HF; Yang YS; Ho HN; Chuang SM; Hsieh FJ
    J Formos Med Assoc; 1994; 93(11-12):954-7. PubMed ID: 7633201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ovarian and peripheral venous steroids in XY gonadal dysgenesis and gonadoblastoma.
    McDonough PG; Ellegood JO; Byrd JR; Mahesh VB
    Obstet Gynecol; 1976 Mar; 47(3):351-5. PubMed ID: 129718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An ovarian lipid cell tumour causing virilization and Cushing's syndrome.
    Elhadd TA; Connolly V; Cruickshank D; Kelly WF
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):723-5. PubMed ID: 8759186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and resection of an oral contraceptive-suppressible Sertoli-Leydig cell tumor with preservation of fertility and a 7-year follow-up.
    Haning RV; Loughlin J; Shapiro SS
    Obstet Gynecol; 1989 May; 73(5 Pt 2):901-5. PubMed ID: 2523030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of ovarian wedge resection on circulating gonadotropin and ovarian steroid levels in patients with polycystic ovary syndrome.
    Judd HL; Rigg LA; Anderson DC; Yen SS
    J Clin Endocrinol Metab; 1976 Aug; 43(2):347-55. PubMed ID: 950366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian Sertoli-Leydig cell tumor with elevated serum alpha-fetoprotein.
    Motoyama I; Watanabe H; Gotoh A; Takeuchi S; Tanabe N; Nashimoto I
    Cancer; 1989 May; 63(10):2047-53. PubMed ID: 2467733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ethinyl estradiol administration and plasma steroid concentrations in ovariectomized women.
    Mahajan DK; Billiar RB; Jassani M; Little AB
    Am J Obstet Gynecol; 1978 Feb; 130(4):398-402. PubMed ID: 147028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gynandroblastoma of the ovary.
    Jaworski RC; Fryatt JJ; Turner TB; Osborn RA
    Pathology; 1986 Jul; 18(3):348-51. PubMed ID: 3785986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testosterone/androstenedione ratio in the evaluation of women with ovarian androgen excess.
    Wiebe RH; Morris CV
    Obstet Gynecol; 1983 Mar; 61(3):279-84. PubMed ID: 6296743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Androgen and estrogen formation in women with ovarian hyperthecosis.
    Aiman J; Edman CD; Worley RJ; Vellios F; MacDonald PC
    Obstet Gynecol; 1978 Jan; 51(1):1-9. PubMed ID: 619322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.